REQUEST A DEMO
Total
USD $0.00
Search more companies

Marlo Farma D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Marlo Farma D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Marlo Farma D.O.O. Beograd is based in Serbia, with the head office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on January 10, 1994. The total number of employees is currently 83 (2023). From the latest financial highlights, Marlo Farma D.O.O. Beograd reported a net sales revenue increase of 8.37% in 2023. A growth of 14.69% was recorded in its total assets.

Headquarters
Neznanog Junaka 23
Belgrade; Belgrade; Postal Code: www.marlofarma.co.rs

Contact Details: Purchase the Marlo Farma D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Marlo Farma D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Marlo Farma D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Marlo Farma D.O.O. Beograd report to view the information.
Incorporation Date:
January 10, 1994
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Gama Pet D.O.O. Zrenjanin
100%
Onlypet - U Likvidaciji
100%
Opet Pet
100%
Company Performance
Financial values in the chart are available after Marlo Farma D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
8.37%
Total operating revenue
8.41%
Operating profit (EBIT)
N/A
EBITDA
-71.89%
Net Profit (Loss) for the Period
N/A
Total assets
14.69%
Total equity
-45.35%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
227%
Quick Ratio
-0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?